QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
ADT, also known as hormone therapy, is typically offered to patients who either have rising PSAs after being treated for prostate cancer or to patients who are not eligible for treatment to due age, life expectancy, or locally advanced disease….
The study focused on aggressive prostate cancer, defined as cancers with a high grade or which resulted in death. For every 4-inch increase in waist size, there was a 13% increase in having high grade prostate cancer. The risk of…
Online tools and technology continue to make it easier for patients and their families to access current research in the medical field. Google Scholar is a specialized search engine created by Google. It provides a simple way to search for…
Earlier research has linked vigorous physical exercise with a lower risk of death from prostate cancer. This new study found that moderate levels of exercise are also associated with a reduced risk of prostate cancer death. Researchers evaluated data from…
Last summer, the National Cancer Institute (NCI) awarded an $11.5 million 5-year grant to the Prostate SPORE (Specialized Project of Research Excellence) at Northwestern University. Dr. Catalona is Principal Investigator of this collaborative research group and co- leads one of…
Screening for prostate cancer with PSA testing has been shown to reduce death and the spread of prostate cancer. However, the PSA test remains controversial due to concerns of over-diagnosis and over-treatment. Clinicians and patients need smarter screening strategies to…
In the 1960s and 70s, several researchers independently identified proteins later shown to have the same amino acid sequence as PSA. T. Ming Chu’s laboratory at the Roswell Park Memorial Institute developed PSA as a biomarker and patented it in…
Studying the genetics of these patients will most likely be the way to find the genes involved in developing aggressive or non- aggressive prostate cancer. Dr. Catalona* wants active surveillance patients to contact his research group for participation in a…
The study authors provided a questionnaire to oncology health care professionals in the Middle East and identified 44 herbal and 3 non-herbal nutritional supplements in use by patients with cancer. The study reviewed the herbal products to assess potential negative…
Men with baldness of any kind had a 56% higher risk of prostate cancer death compared to men with no balding. Men with moderate balding had an even higher risk of 83%. Previous studies have shown a link between baldness…
"*" indicates required fields
